Bor-wen Wu Ph.d., M.b.a.

Biography

 Dr. Bor-Wen Wu, Ph.D., M.B.A. serves as the President and Chief Executive Officer at Polaris Pharmaceuticals, Inc. Dr. Wu spent 13 years as a biochemist at Agouron Pharmaceuticals, Inc., Warner-Lambert, and Pfizer. As a Member of the structure-based drug design team, he made significant contribution to the development of Viracept, an HIV protease inhibitor for the treatment of HIV. In addition to working on other HIV-related projects, he also served as an oncology project leader and was a member of the Ophthalmology Strategic Planning Committee. In 2002, he founded DesigneRx Pharmaceuticals, Inc., a pilot cGMP facility for biologics in California. In 2003, he founded TDW Pharmaceuticals, Inc., a Taiwan-based pharmaceutical company developing treatments for cancer and gout. In 2006, he co-founded Polaris Group and Polaris Pharmaceuticals, Inc. Dr. Wu earned his Ph.D. from the University of California, Irvine.

Research Interest

Developing treatments for cancer.